|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 112,700 KRW | +1.17% |
|
+1.81% | -3.51% |
| 04-24 | Korean Sugar Imports Plunge 14% as Diabetes Cases Surge | MT |
| 04-12 | AEON Biopharma, Inc. announced that it has received $15 million in funding from Daewoong Pharmaceutical Co., Ltd | CI |
Daewoong pharmaceutical Co.,Ltd reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 322,414.53 million compared to KRW 298,355.7 million a year ago. Net income was KRW 15,409.32 million compared to KRW 13,618.71 million a year ago.
Basic earnings per share from continuing operations was KRW 1,379 compared to KRW 1,230 a year ago. Basic earnings per share was KRW 1,379 compared to KRW 1,230 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.51% | 952M | |
| +21.59% | 44.15B | |
| +23.03% | 23.02B | |
| +18.22% | 15.33B | |
| +12.26% | 13.74B | |
| +52.55% | 12.16B | |
| -10.02% | 6.84B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.92% | 5.66B |
DAEWOONG PHARMACEUTICAL CO., LTD 
